![Federico Bolognani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Federico Bolognani
Corporate Officer/Principal presso Axial Therapeutics, Inc.
Provenienza dei contatti di primo grado di Federico Bolognani
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Axial Therapeutics, Inc.
![]() Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA.
14
| Holding Company | Pharmaceuticals: Major | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Federico Bolognani tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
REVVITY, INC. | Medical Specialties | Corporate Officer/Principal | |
INSMED INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Mitobridge, Inc.
![]() Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Chief Executive Officer Director of Investments | |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Domain Associates LLC
![]() Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
Kira Biotech Pty Ltd.
![]() Kira Biotech Pty Ltd. BiotechnologyHealth Technology Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia. | Biotechnology | Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
The University of Queensland | College/University | Undergraduate Degree | |
Georgetown University | College/University | Undergraduate Degree | |
Lantheus Medical Imaging, Inc.
![]() Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Medical Specialties | Director of Finance/CFO | |
TransMedics, Inc.
![]() TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Medical Specialties | Director of Finance/CFO | |
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Medical Specialties | Director/Board Member | |
Synglyco, Inc.
![]() Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
St. Francis Xavier University | College/University | Undergraduate Degree | |
Queen's University | College/University | Doctorate Degree | |
OneVentures Management Pty Ltd.
![]() OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Investment Managers | Private Equity Investor | |
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Consultant / Advisor | |
TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Jnana Therapeutics, Inc.
![]() Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
IKENA ONCOLOGY, INC. | Biotechnology | Chairman | |
Newton-Wellesley Hospital Corp.
![]() Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Newton-Wellesley Hospital Corp. provides health care services. Its services include medical, surgical and diagnostic services. The company was founded in 1881 and is headquartered in Newton, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Upstream Bio, Inc.
![]() Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Chairman | |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bain Capital Holdings LP
![]() Bain Capital Holdings LP MiscellaneousMiscellaneous Bain Capital Holdings LP is an investment holding company. The company is headquartered in Boston, MA. | Miscellaneous | Private Equity Investor | |
American Liver Foundation of Northern California | Director/Board Member | ||
Bain Capital Life Sciences LP
![]() Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
University of Basel | College/University | Doctorate Degree | |
Cell Medica Switzerland AG
![]() Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cullinan Pearl Corp.
![]() Cullinan Pearl Corp. BiotechnologyHealth Technology Part of Otsuka Holdings Co., Ltd., Cullinan Pearl Corp. is a company that develops an orally available tyrosine kinase inhibitor. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. Cullinan Pearl was acquired by Taiho Pharmaceutical Co., Ltd. from Cullinan Oncology, Inc. on June 23, 2022 for $405 million. | Biotechnology | Director/Board Member | |
University of Tokyo | College/University | Doctorate Degree | |
UTokyo Innovation Platform Co.,Ltd.
![]() UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
Stati Uniti | 32 |
Australia | 6 |
Francia | 3 |
Canada | 3 |
Svizzera | 3 |
Settori
Health Technology | 26 |
Finance | 10 |
Consumer Services | 8 |
Commercial Services | 3 |
Health Services | 2 |
Posizioni
Director/Board Member | 99 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 20 |
Founder | 18 |
Chairman | 14 |
Contatti più connessi
Insiders | |
---|---|
James Blair | 48 |
Richard H. Aldrich | 31 |
Ronald Renaud | 24 |
Eric Forquenot de la Fortelle | 19 |
Sakae Asanuma | 12 |
Scott Brun | 12 |
Jeffrey E. Young | 10 |
Nora Frey | 8 |
A. Stewart Campbell | 7 |
Sarah J. Meibusch | 6 |
Makoto Ohori | 6 |
Sarkis K. Mazmanian | 2 |
Chris Meyer | 1 |
Steven Opal | 1 |
- Borsa valori
- Insiders
- Federico Bolognani
- Connessioni Società